Company Updates

Highlights:
36 human subjects successfully dosed in the Phase I intravenous (IV) clinical trial of RECCE® 327 (R327) – good safety & tolerability
Independent Safety Committee affirms ‘low-dose’ cohor

$6.1 Million investment for Pictor — led by Marko Bogoievski and K One W One Ltd. — to aid the market development of novel antibody testing and other in vitro diagnostics

EpiAxis Therapeutics has welcomed biomedical scientist Dr Darren Saunders as its new Chief Science Officer.
The appointment follows Dr Saunders joining EpiAxis Therapeutics in October 2021 as Science

Is marketplace lending to property developments different to traditional property investment? In this article, we examine how the two compare.

What is marketplace lending?
In a property development

Tiro, from Lexical Labs, is the most advanced AI based automated contract review system available. Tiro reviews contracts – using both deep learning and logic based algorithms – just like a lawyer or

The “Innovator of the Year” awarded INOPTEC has just raised 250k EUR from a strategic plastic part supplier this week, on top of the 1 Mio. EUR which was already raised.
INOPTEC has developed and pate

If your flight has ever been delayed or cancelled due to poor visibility, you might have wondered if there’s a solution to runway fog.

Well, Christchurch-based Pyper Vision say they have cracked it.

Kikapay continues to grow with a national car park operator moving to solution workshops for Kikapay’s Fine payment solution. This represents another intelligent payment solution we are developing. We

With the recent addition of Bordeaux (UBB) as a partner, FRW has solidified its position as a leader in the world of fantasy rugby. Bordeaux joins more than ten other professional leagues and teams a